Friday, September 27th, 2024

DRB-Hicom Signals Strong Recovery with Bullish Momentum

Date: 26 September 2024
Broker: UOB Kay Hian Securities (M) Sdn. Bhd.


Overview of DRB-Hicom

DRB-Hicom (DRB MK) is a diversified company involved in several key industries, including automotive, services, and property sectors. The company is a prominent player in the Malaysian market, particularly known for its role in the automotive sector, which includes partnerships and operations with global automotive brands.

Market Data:

  • Last Price: RM1.18
  • Target Price: RM1.29 (near-term), RM1.38 (mid-term)
  • Support Level: RM1.05
  • Stop-loss: RM1.04

Technical Analysis and Buy Recommendation

UOB Kay Hian has issued a “Technical BUY” recommendation for DRB-Hicom, highlighting its recovery momentum and potential return of +16.9%. The stock price is gradually recovering and has moved above key short-term moving averages (7- and 21-day Exponential Moving Averages or EMAs), signaling a bullish outlook.

Key technical indicators are supportive of further gains:

  • DMI Indicator: Shows that positive momentum is strengthening.
  • Volume: The recent price increase has been supported by a higher trading volume, indicating strong buying interest.

Target Price and Timeframe

  • Target Price 1: RM1.29
  • Target Price 2: RM1.38
  • Expected Timeframe: Two weeks to two months

The broker’s analysis suggests that DRB-Hicom’s share price is positioned to move higher in the near term, driven by technical indicators and rising investor sentiment.

Key Risks

Despite the positive technical outlook, there are risks associated with the stock, including:

  • Stop-Loss Level: The stock has a stop-loss level at RM1.04, meaning if the price dips below this level, the technical buy recommendation would be invalidated, and further downside risk could emerge.

In conclusion, DRB-Hicom presents a compelling technical buy opportunity with favorable short-term price momentum and potential upside, making it an attractive option for traders looking for near-term gains.

KPJ Healthcare Berhad

KPJ Healthcare Berhad (KPJ), focusing on its financial performance for the second quarter of 2024 (2Q24) and the first half of 2024 (1H24). The report also provides an outlook on the company’s future performance...

Automobile – China

Automobile – China Weekly: PV Sales Rebound By 10% yoy; Beat Expectations China’s PV insurance registrations rebounded by 10% yoy and 13% wow to 514,134 units in the week of 26 Aug-1 Sep 2024....

Why is CIMB group undervalued?

CIMB Group Holdings has been trading below the sector’s valuations